How A Decades-Old Medical Records Company Made A Huge AI Bet To Save Itself
Veradigm's interim CEO Yin Ho has an audacious plan to reinvent what was formerly Allscripts with the $140 million acquisition of AI startup ScienceIO.
Veradigm's interim CEO Yin Ho has an audacious plan to reinvent what was formerly Allscripts with the $140 million acquisition of AI startup ScienceIO.
What's Your Reaction?
